Table of Contents
Overview
Lack of Consensus on Disease Definition
Underdiagnosis
Therapeutic Options
Reimbursement Environment
Drugs in Development
Validity of Metabolic Syndrome As a Distinct Disease
Outlook and Implications for the Pharmaceutical Industry
|